Kevin Robert Lind is CFO & VP at ARENA PHARMACEUTICALS INC (ARNA). They have made 1 open-market trade across 1 company since 2020, most recently 2024-12-02.
CIK 0001677036
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARNA | SELL | 2020-02-13 | 2020-02-14 | $55.00 | $248K | -18.2% | -32.6% | -16.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.